CardioSafe+: A Platform for Telerehabilitation and Monitoring of Patients With Heart Problems
- Conditions
- Cardiovascular Diseases
- Interventions
- Other: Home-based exercises
- Registration Number
- NCT05865158
- Lead Sponsor
- University of Salamanca
- Brief Summary
The use of telerehabilitation seems to be effective in managing complications after suffering a cardiovascular pathology. The use of the CardioSafe+ digital platform is suggested for the management of these complications. For this reason, an intervention will be carried out to determine the effectiveness of this platform. A total of 60 participants will be recruited to carry out a home-exercise intervention through CardioSafe+ for 6 weeks. Maximun respiratory pressures, exertion capacity, and subjective sensation of exertion will be assessed.
- Detailed Description
This intervention seeks to determine the effectiveness of the CardioSafe+ digital platform in aiding individuals recovering from cardiovascular pathologies. By involving a group of 60 participants in a structured six-week home-exercise program using the CardioSafe+ platform, the objective is to measure and evaluate various factors related to their physical well-being and recovery.
Key components to be evaluated include:
Maximal Respiratory Pressures: This involves measuring the maximum force generated during inspiration and expiration, which can indicate respiratory muscle strength and function.
Exertion Capacity: The assessment aims to gauge the participants' ability to engage in physical activities, potentially reflecting improvements in overall cardiovascular fitness and endurance.
Subjective Sensation of Exertion: This component involves understanding how the participants perceive and rate their own exertion during exercises, contributing to insights about their subjective experience and effort perception.
The intervention's objective is to collect data on these parameters before and after the six-week exercise program utilizing the CardioSafe+ digital platform. This data will help determine the effectiveness of the platform in aiding individuals recovering from cardiovascular pathologies and could provide valuable insights for further implementing tele-rehabilitation in managing such health complications.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 60
- People who present a cardiovascular pathology with more than one year of evolution.
- To be in a stable medical situation.
- To have access to technological resources and knowledge for their use.
- People who present any contraindication established for carrying out physical activity.
- People who present insufficient capacity to understand and obey the instructions offered by the researchers, both in the evaluation and in the intervention.
- People who have a cardiac pathology with obvious fluctuations in the course of the disease.
- The presence of an acute episode of the disease during the intervention period.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Community-dwelling group Home-based exercises Group of community-dwelling people with chronic cardiovascular diseases. Institionalized group Home-based exercises Group of institutionalized people with chronic cardiovascular diseases.
- Primary Outcome Measures
Name Time Method 2 minute stationary walk test 6 weeks Effort test in which the participant is asked to lift their knees for 2 minutes and the number of times is counted. Based on that number, the percentile in which the person is based on their age and sex is calculated.
Maximum expiratory pressure by spirometry 6 weeks Value of the maximum expiratory capacity in mm of H2O.
Maximum inspiratory pressure by spirometry 6 weeks Value of the maximum inspiratory capacity in mm of H2O.
Borg Rating of Perceived Exertion Scale 6 weeks Scale of perceived subjective effort in which it is valued with a score of 0 to 10, subjectively. Started from 0 where your breathing is causing you no difficulty at all and progresses through to number 10 where your breathing difficulty is maximal.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Beatriz María Bermejo Gil
🇪🇸Salamanca, Spain